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Gender is an independent risk factor for
distribution pattern and lesion morphology in
chronic critical limb ischemia
Jana Ortmann, MD,a Eveline Nüesch, PhD,b Tobias Traupe, MD,c Nicolas Diehm, MD,a and
Iris Baumgartner, MDa Bern, Switzerland
Background: The aim of this study was to determine gender differences in atherosclerotic lesion morphology and
distribution pattern of patients with critical limb ischemia (CLI).
Methods: In this prospective cohort study, 233 patients, including 134 men (58%) and 99 women (43%) presenting with
critically ischemic limbs were consecutively enrolled. Lesions of the entire lower limb arterial tree were evaluated and
grouped into iliac, femoropopliteal, and below-the-knee (BTK) arterial disease. To elucidate whether gender is an
independent risk factor for distribution pattern, we performed multivariable logistic regression models adjusted for
cardiovascular risk factors.
Results: At time of diagnosis, women with CLI presented with higher mean age (78 10 vs 74 10, P  .01), suffered
more often from hypertension (83% vs 71%, P .04), and fewer were current or former smokers (25% vs 70%, P< .001).
After multivariate analysis, women with CLI showed a 2.5-fold higher risk for femoropopliteal lesions (odds ratio [OR],
2.53; 95% confidence interval [CI], 1.05-6.11, P  .04), with a threefold higher risk for occlusions compared with men
(OR, 3.81; 95% CI, 1.45-10.0; P .01). Moreover, in women a higher risk for multilevel disease was observed (OR, 3.81;
95% CI, 1.45-10.0; P  .01). In contrast, men presented more often with isolated BTK lesions compared with women
(OR, 0.15; 95% CI, 0.05-0.70; P  .03).
Conclusions: The finding that female gender may be an independent predictor for pronounced femoropopliteal involve-
ment and more severe and diffuse atherosclerotic disease in CLI may be of particular relevance for early detection and for
choosing distinct treatment strategies in women compared with men. Further studies are warranted, especially on
confounding risk factors that might be different in men and women and their possible association with lesion morphology
in patients with critical limb ischemia. (J Vasc Surg 2012;55:98-104.)
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tChronic critical limb ischemia (CLI), representing the
most severe form of peripheral artery disease (PAD), is
defined as the presence of rest pain, ulceration, or gangrene
and the prognosis for potential limb salvage is dismal and
even higher if left untreated.1 CLI is associated with in-
creased mortality and patients are at an exceptionally high
risk for other cardiovascular events.1 Cardiovascular dis-
eases, including CLI, are responsible for the largest portion
of health-care expenses and account for the highest rates of
morbidity and mortality in women (42%), which even
exceed the rates for men (35%).2 During the past decade,
cardiovascular death, including death from CLI, has de-
creased among men, whereas women have experienced a
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98ontinuous increase of cardiovascular mortality, despite
mproved diagnostic approaches and continuing advances
n medical therapy.2,3
Based on numerous previous studies, it is anticipated
hat women with CLI have higher amputation rates and
ower graft4 or stent patency5,6 rates as well as more wound
omplications7 after revascularization than men. Most of
hese differences in outcomes following revascularization
ave been attributed to delayed presentation, smaller vessel
iameter, advanced age, and comorbidities.4,5,8,9 How-
ver, beyond these differences certain pathomorphologic
ender differences have also been suggested since it seems
hat in women after menopause atherosclerotic disease is
ore rapidly progressing and more diffuse in women after
enopause when compared with men.10,11 A position
aper of the AmericanMedicalWomen’s Association stated
hat only 25% of research studies were analyzed by gen-
er.12 Yet, since the US National Institute of Health
trongly recommended representative inclusion of women
n clinical research, gender differences in cardiovascular
isease have gained increased attention and evidence-based
ender-specific treatment guidelines have already been re-
eased for coronary artery disease and cerebrovascular dis-
ase.13,14
Although the indications for immediate revascular-
zation have been established for CLI,1 a more informa-
ive morphologic picture to describe the typical arterial
nvolvement may be of value to design specific treatment
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Volume 55, Number 1 Ortmann et al 99guidelines for men and women suffering from CLI. To
date, only very few studies investigating the impact of
gender on CLI4,5,15 have been performed and data on
lesion pathomorphology and distribution patterns in an
unselected female CLI cohort investigating the entire
lower leg arterial tree are missing. The aim of this cohort
study of patients with CLI was therefore to analyze
gender differences regarding morphology and distribu-
tion pattern of lower-limb lesions prospectively followed
in “all comer” patients treated in a large tertiary referral
center. Moreover, we aimed to determine whether gen-
der is an independent determinant of pathomorphologic
differences by means of multivariate logistic regression
analysis.
METHODS
Study design. Analysis was based on 233 patients
with CLI referred to the Cardiovascular Center at the
University Hospital of Berne between January 1999 and
June 2004 by external general physicians, general hospi-
tals, or the Department of Emergency Medicine of our
institution. Recorded patient details comprised demo-
graphic characteristics, risk factors, clinical presentation,
imaging studies, and treatment modality at initial diag-
nosis of CLI. Approval of the local ethics committee had
been obtained before the beginning of the study. The
study was carried out according to the Declaration of
Helsinki. All patients had given informed consent prior
to inclusion into this study.
The definition of CLI followed the Second European
Consensus document, ie (1) presence of ischemic rest
pain for more than 2 weeks or ischemic tissue loss
associated with (2) an absolute ankle pressure 50 mm
Hg or great toe pressure 30 mm Hg.16 Patients with
acute limb ischemia due to an embolic etiology and onset
of symptoms within 2 weeks before referral were ex-
cluded. All patients included in this study underwent
digital subtraction angiography prior to treatment deci-
sion by a multidisciplinary vascular board. Angiographic
findings of the preinterventional angiography were pro-
spectively entered in a database. Double reading of the
angiography was performed always by the same two
vascular specialists.
All lesions of the arterial tree were grouped as iliac (com-
mon, external, and internal iliac artery), femoropopliteal
(common, superficial and deep femoral arteries, popliteal ar-
tery) and below-the-knee (BTK: tibioperoneal trunk, anterior
and posterior tibial arteries, peroneal artery) as proposed by
Diehm, et al17. All lesions analyzed were assessed visually and
specified as either stenosis (defined as narrowing of lumen
diameter of 50%-99%) or occlusion (no contrast media seen
distal of the lesion). Stenotic lesions were defined as singular
or multifocal. Iliac and femoropopliteal occlusions were sepa-
rated as either10 cm or10 cm. The BTK arterial tree was
described as number of patent vessels.
The following definitions were used: arterial hyperten-
sion was assumed if systolic blood pressure was 140 mm
Hg or diastolic 90 mm Hg at least on two different wccasions, or if the patient was taking antihypertensive
edication. Dyslipidemia was defined by a total serum
holesterol level of 5 mmol/L, serum high-density lipo-
rotein cholesterol level of 1 mmol/L, or serum triglyc-
ride level of 2 mmol/L. Diabetes mellitus was defined
y fasting blood sugar levels 120 mg/dL, a hemoglobin
1c level 6%, or intake of antidiabetic drugs. Smoking
abits were divided into either current or former smoking,
r nonsmoking. Renal failure was defined as a serum creat-
nine level 130 mol/L.
Statistical analysis. All analyses are based on patients
ith complete data sets. Continuous and normally distrib-
ted variables are presented as mean  standard deviation,
nd asymmetrically distributed variables as median (inter-
uartile range). Categorical variables are presented as num-
ers (percentages). Baseline characteristics were analyzed
sing Student t test or Mann-Whitney test for continuous
nd 2 test for categorical data.
Associations between gender and morphologic charac-
eristics of vascular lesions (lesion present, type of lesion
nd length of occlusion, tibial vessel patency, lesions
reated, multilevel disease and localization of treated le-
ions) were determined using crude univariable and multi-
ariable logistic regression models adjusted for age, smok-
ng, presence of hypertension, dyslipidemia or statin use,
nd diabetes. Differences between gender and morpho-
ogic characteristics were tested using Wald tests for trend
r interaction as appropriate. All P values and 95% confi-
ence intervals were two-sided.
ESULTS
Cohort description and patient characteristics.
wo hundred forty-nine patients with critically ischemic
imbs were consecutively enrolled into the registry, 16
atients (6%, seven men and nine women) were excluded
ue to incomplete data. A total of 233 patients, includ-
ng 134 men (58%) and 99 women (42%) with critically
schemic limbs were consecutively enrolled in our study
nd contributed to all analyses. Detailed demographic
ata and clinical characteristics of men and women at
aseline are given in Table I. Compared with men,
omen presented with a higher mean age (78 10 vs
4  10, P  .01), suffered more often from hyperten-
ion (83% vs 71%, P  .04), and were less often current
r former smokers than men at time of CLI diagnosis
25% vs 70%, P  .001).
Gender-specific differences of lesion morphology
nd distribution pattern of the iliac axis in patients with
LI. Arterial lesions of the iliac axis are shown in Table
I. A minority of all lesions involved the iliac axis, namely
9% in men and 17% in women (P  .77). All lesions of
he iliac axis were combined with lesions of other seg-
ents of the arterial tree (see below). In univariable
nalyses, no difference in lesion severity, in particular
umber of occlusions or occlusion length, was observed
etween men and women (P  .77, Table II). However,
hen adjusted for cardiovascular risk factors, we found a
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January 2012100 Ortmann et altendency for a higher risk of more severe iliac lesions in
women compared to men (P  .08).
Gender-specific differences of lesion morphology
and distribution pattern of the femoropopliteal axis in
patients with CLI. Overall, 84% of all lesions involved the
femoropopliteal axis. There was a trend toward more fem-
oropopliteal lesions in women (P  .09), and when ad-
justed for risk factors, the risk for femoropopliteal lesions
was 2.5-fold higher in women compared with men (P 
.04, Table III). Of all femoropopliteal lesions, most were
occlusions (58%), in particular 66% of all occlusions mea-
sured 10 cm in length (Table III). In general, a trend
toward more severe femoropopliteal lesions in women
compared with men was observed (P .05), which became
significant after adjusting for risk factors (P  .02). There-
fore, women had an almost twofold increased risk for
stenoses and a more than threefold increased risk for occlu-
sions of the femoropopliteal axis as compared with men
(P  .02).
Gender-specific differences of lesion morphology
and distribution pattern of the BTK axis in patients
with CLI. Almost all men and women with CLI presented
with BTK lesions, only 1% of both genders showed patency
Table I. Demographic and clinical patient characteristics a
Characteristic
All patients
N  233
Age, mean (SD) 76 (10)
PTA, n (%) 172 (74%)
Creatinine, umol/L, median (IQR) 103 (87-132)
Dialysis, n (%) 16 (6.9%)
Hypertension, n (%) 177 (76%)
Hyperlipidemia, n (%) 128 (55%)
Diabetes, n (%) 118 (51%)
Former and current smoking, n (%) 119 (51%)
IQR, Interquartile range; n, number; PTA, percutaneous transluminal angi
P values are derived from 2 tests for categorical variables and from Student
Table II. Characterization of arterial lesions of the iliac ax
Iliac axis
Men
n 134
Women
n  99
Iliac lesion present
No 109 (81%) 82 (83%) 1.
Yes 25 (19%) 17 (17%) 0.
Type of lesion
None 109 (81%) 82 (83%) 1.
Stenosis 16 (12%) 8 (8%) 0.
Occlusion 9 (7%) 9 (9%) 1.
Length of occlusionb
10 cm 4 (50%) 5 (56%) 1.
10 cm 4 (50%) 4 (44%) 0.
95% CI, 95% Confidence interval; OR, odds ratio; n.e., not estimable.
aAdjusted for age, smoking, presence of hypertension, hyperlipidemia, and
bFor one male patient, occlusion length was not available.of all three arteries in the BTK segment (Table IV). Con- serning the number of patent vessels of BTK lesions, no
ifference was observed (P  .62), also when adjusted for
ardiovascular risk factors (P  .50).
Gender differences of lesion localization and be-
ween single and multilevel disease in patients with
LI. Gender-specific differences in lesion localization and
etween single andmultilevel disease are shown in Table V.
e observed a 2.6-fold increase of the risk for involvement
f multiple segments of the arterial tree in female patients
ompared with men (P  .03) which increased to almost
ourfold after adjustment for risk factors (P  .01). The
ocalization of lesion involvement was different between
en and women (P for interaction  .03 after multivari-
ble adjustment). In particular, women showed more
nvolvement of the femoropopliteal or iliac axis com-
ined with BTK lesions (92% vs 81%), whereas men
resented with more isolated BTK lesions compared
ith women (18% vs 7%).
ISCUSSION
This prospective cohort study with 233 prospectively
nrolled patients with CLI in a large tertiary vascular
eferral center is to the best of our knowledge the first
eline
Men Women
P valuen  134 n  99
74 (10) 78 (10) .01a
102 (76%) 70 (71%) .35
109 (89-141) 99 (87-124) .12b
10 (7.6%) 6 (6.1%) .65
95 (71%) 82 (83%) .04
69 (51%) 59 (60%) .22
72 (54%) 46 (46%) .27
94 (70%) 25 (25%) .001
y; SD, standard deviation.
( a) or Mann-Whitney-U test ( b) for continuous variables.
nivariable analysis Multivariable analysis
de OR
% CI) P value
Adjusted ORa
(95% CI) P value
.77 .16
ef) 1.00 (ref)
.46-1.78) 1.80 (0.79-4.12)
.91 .08
ef) 1.00 (ref)
.27-1.63) 1.23 (0.43-3.47)
.51-3.50) 3.15 (0.96-10.4)
.82 n.e.
ef) 1.00 (ref)
.12-5.40) n.e.
es.t bas
oplastis
U
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80 (0tudy analyzing the entire arterial tree of an all comers
a
s
p
w
r
s
diabet
diabet
diabet
JOURNAL OF VASCULAR SURGERY
Volume 55, Number 1 Ortmann et al 101CLI cohort and demonstrating that gender differences
exist concerning lesion morphology and distribution
patterns. We demonstrate that women with CLI after
adjustment for risk factors still bear an increased risk for
femoropopliteal lesions and specifically for occlusions.
Moreover, female gender is associated with a higher risk
Table III. Characterization of arterial lesions of the femor
Femoropopliteal axis
Men
n  134
Women
n  99
Femoropopliteal lesion present
No 26 (19%) 11 (11%)
Yes 108 (81%) 88 (89%)
Type of lesion
None 26 (19%) 11 (11%)
Stenosis 49 (37%) 34 (34%)
Occlusion 59 (44%) 54 (55%)
Length of occlusion
10 cm 22 (37%) 16 (30%)
10 cm 37 (63%) 38 (70%)
95% CI, 95% Confidence interval; OR, odds ratio.
aAdjusted for age, smoking, presence of hypertension, hyperlipidemia, and
Table IV. Characterization of arterial lesions below-the-k
Below-the-knee (BTK)
Men
n  134
Women
n  99
Tibial vessel patency
None 46 (34%) 33 (33%) 1.0
1 vessel 72 (54%) 51 (52%) 0.9
2 vessels 15 (11%) 14 (14%) 1.3
3 vessels 1 (1%) 1 (1%) 1.3
95% CI, 95% Confidence interval; OR, odds ratio.
aAdjusted for age, smoking, presence of hypertension, hyperlipidemia, and
Table V. Characterization of arterial lesions according to
Men
n 134
Women
n  99
Type of disease
Unilevel disease 25 (19%) 8 (8%)
Multilevel disease 109 (81%) 91 (92%)
Localization of lesions
Iliac, femoropopliteal, and
crural lesions
23 (17%) 13 (13%)
Iliac and crural lesions 2 (1%) 4 (4%)
Femoropopliteal and crural
lesions
84 (63%) 74 (75%)
Femoropopliteal lesions only 1 (1%) 1 (1%)
Crural lesions only 24 (18%) 7 (7%)
95% CI, 95% Confidence interval; OR, odds ratio.
aAdjusted for age, smoking, presence of hypertension, hyperlipidemia, and
bP value for interaction.for diffuse disease involving multiple segments of the Crterial tree. In contrary, men presented with more le-
ions limited to the BTK axis. Since these differences are
resent when adjusted for cardiovascular risk factors,
e conclude that female gender may be an independent
isk factor for femoropopliteal involvement and a more
evere and diffuse atherosclerotic disease pattern in
liteal axis
Univariable analysis Multivariable analysis
Crude OR
(95% CI) P value
Adjusted ORa
(95% CI) P value
.09 .04
0 (ref) 1.00 (ref)
3 (0.90-4.11) 2.53 (1.05-6.11)
.05 .02
0 (ref) 1.00 (ref)
4 (0.72-3.76) 1.95 (0.75-5.10)
6 (0.98-4.79) 3.12 (1.22-7.97)
.39 .47
0 (ref) 1.00 (ref)
1 (0.64-3.10) 1.41 (0.55-3.61)
es.
nivariable analysis Multivariable analysis
e OR
CI) P value
Adjusted ORa
(95% CI) P value
.62 .50
f) 1.00 (ref)
56-1.75) 0.94 (0.48-1.82)
55-3.06) 1.49 (0.55-4.06)
08-23.1) 2.73 (0.09-83.0)
es.
mic level
Univariable analysis Multivariable analysis
Crude OR
(95% CI) P value
Adjusted ORa
(95% CI) P value
.03 .01
0 (ref) 1.00 (ref)
1 (1.126.06) 3.81 (1.45-10.0)
.10b .03b
0 (ref) 1.00 (ref)
4 (0.5722.0) 3.43 (0.42-27.9)
6 (0.743.29) 0.80 (0.32-1.96)
7 (0.1030.7) 1.81 (0.06-58.7)
2 (0.171.52) 0.19 (0.05-0.70)
es.opop
1.0
1.9
1.0
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1.0
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now appreciated in cardiovascular research, gender differ-
ences in peripheral artery disease are still not completely
understood. Surgical and endovascular revascularization
trials have shown that women present with a higher com-
plication rate and worse outcomes.4-7 Whether these worse
outcomes in women are only due to disadvantageous pre-
interventional profile or whether gender-specific patho-
morphologic determinants might play a role independently
of cardiovascular risk factors is not clear.
Our study demonstrates that women present with a
higher risk for lesions of the femoropopliteal segment,
especially for more occlusions, when adjusted for risk
factors. In patients with peripheral artery disease of all
stages, gender-related effects on site selectivity of athero-
sclerotic lesions were shown in a cohort study of our
group, including 1583 men and 1076 women.17 In line
with our CLI data presented here, this study demon-
strated that female gender is associated with pronounced
femoropopliteal involvement, whereas men present with
more BTK lesions.17 In accordance to our study, Hult-
gren and coworkers also have shown more BTK involve-
ment in men compared with women with CLI, although
no differentiation between single lesions and multilevel
disease was performed.15 However, Hultgren et al con-
sidered only part of the atherosclerotic burden since only
target lesions revascularized by surgical or endovascular
means, independently of concomitant untreated lesions,
were included in the analysis. Therefore, it is very likely
that severe lesions, which were not feasible for revascu-
larization, were not analyzed. Furthermore, we believe
that the higher percentage of iliac lesions in women in
that study might be due to the fact that more iliac
revascularization procedures in women were performed
to improve inflow. Importantly, no adjustment for car-
diovascular risk factors was performed and no differenti-
ation concerning severity of lesions as presented in our
analysis were shown. Accordingly, the strength of the
present study was that all lesions of the entire vascular
tree were assessed prospectively from an unselected CLI
population, and that adjustment for risk factors by mul-
tivariate analysis was performed. Importantly, the pro-
portion of women in this study and the total proportion
of lesion distribution of our patient cohort is similar to
other CLI series.18-20
Large epidemiologic and autopsy-based studies have
shown that distribution, extent, and progression of athero-
sclerosis are influenced by cardiovascular risk fac-
tors.17,21,22 Therefore, associations between anatomic le-
sions and gender might be confounded by traditional
cardiovascular risk factors. Indeed, in our series, adjust-
ments for these potential confounders unravel the effect of
gender on lesion morphology and distribution pattern in
patients with CLI, which became significant for femoro-
popliteal lesions and specifically for occlusions. The higher
mean age observed in women is well in accordance with
previous studies,4,5,8,15,23 andmight be due to a later onset ef disease, possibly resulting from the protective effects of
ndogenous estrogens before menopause.11
Moreover, women tend to present at later stages of
isease due to misdiagnosis and ignoring of symptoms of
oth the patient and the physician. They are also more
earful and skeptical towards health care providers and are
ften caregivers for others, which altogether may also ac-
ount for the higher mean age of women compared with
en.24-28 The higher prevalence of hypertension and the
ower rate of smokers among women with CLI was also
reviously reported.15 Since the cardiovascular risk burden
lays a pivotal role for extent and progression of atheroscle-
otic lesions, adjustment for risk factors unmasks the role of
ender in these patients with CLI.
Of note, our finding that women present more often
ith more severe and more multilevel disease than men
ight be explained by the more rapidly progressing and
ore diffuse atherosclerotic disease process observed in
omen after menopause, when the protective effects of
strogens are lost.10,29 Hypotheses explaining female gen-
er as an independent risk factor for pathomorphologic
eterminants of atherosclerotic lesions in CLI include he-
odynamic changes related to arterial morphology and
ellular or biochemical variations in the arterial wall.30
herefore, differences in vascular anatomy, including in-
reased arterial stiffness and a smaller lumen diameter in
omen leading to regional disturbances of blood flow,
ight be contributory reasons for the gender differences in
he pathomorphologic pattern demonstrated.9-11,29 More-
ver, the special role of oxidative stress indicated by in-
reased levels of biomarkers,31 and local changes in the
rterial wall leading to endothelial and smooth muscle cell
ysfunction shown in women might also play a role.11,32,33
Limitations. The following limitations of our study
ave to be discussed. First, we have corrected the data for
ifferent cardiovascular risk factors known to influence
utcome in vascular interventions. However, these factors
epresent only a small number of possible confounding
actors. Accordingly, we cannot exclude residual confound-
ng that might have biased our estimates in any direction.
econd, we are aware that grouping the treated vessels into
hree categories might be an over-simplification, and we
ight have overlooked some details of interest. However, a
ore differentiated analysis of vascular territories most
ikely would not have changed the main findings of the
resent study. Further, possible hormone replacement
herapy, which might have influenced lesion patterns, was
ot assessed, and all patients with a first time CLI diagnosis
ere enrolled irrespective of any past history of revascular-
zation. Therefore, lesions considered in this study may
epresent recurrent, not de novo lesions. However, this
oes not affect the pathomorphologic features in men and
omen with CLI.
ONCLUSIONS
The finding that female gender may be an indepen-
ent predictor for severe and diffuse atherosclerotic dis-
ase, particularly of the femoropopliteal axis, may be of
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lesions and for choosing distinct treatment strategies in
women compared to men with CLI. It is known that
female patients with CLI exhibit an increased risk of limb
loss, which can be reduced after successful revasculariza-
tion.1 Since the aim of revascularization is to improve
peripheral tissue perfusion, knowledge of extension and
characteristics of vascular lesions is of major impor-
tance.1 Based on our data, it becomes evident that in
women, endovascular specialists and vascular surgeons
have to be aware that they will encounter more severe
disease of femoropopliteal arteries and diffuse athero-
sclerotic lesions of the femorocrural axis. The common
multilevel disease accompanied with more occlusions in
women with CLI also means that, in case of endovascular
treatment, different techniques and devices may be used
during a revascularization procedure. Importantly, with
a substantial aging population and increasing prevalence
of CLI in women,15,34,35 the treatment of atherosclero-
sis in this patient group will remain an important chal-
lenge for vascular specialists in the future. Therefore,
further studies are warranted, especially on confounding
risk factors, which might be different in men and women
and their possible association with lesion morphology in
patients with critical limb ischemia.
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